Lupin unveils fixed-dose triple drug combination DIFIZMA DPI for inadequately controlled asthma Ruchika Sharma6 Jan 2023 11:38 AM IST"DIFIZMA is the only FDC that has been approved by the Drug Controller General of India (DCGI) for the treatment of inadequately controlled Asthma,"...
Include more Govt sites: CDSCO panel to Zydus Healthcare on clinical trial of Pulmonary disease drug Susmita Roy10 Dec 2022 3:57 PM ISTNew Delhi: Citing that more Govt. sites should be included, the Subject Expert Committee (SEC) functional under the Central Drug Standard Control...
Cipla gets CDSCO Panel nod to manufacture, market COPD drug combination Aerosol for inhalation Susmita Roy23 Nov 2022 6:00 PM ISTNew Delhi: Granting the phase III clinical trial study waiver, the Subject Expert Committee (SEC) functional under the Central Drug Standard Control...
AstraZeneca gets CDSCO panel okay for Clinical Trial Of Asthma drug Budesonide Glycopyrronium Medical Dialogues Team26 March 2021 5:44 PM ISTNew Delhi: The Subject Expert Committee functional under the Central Drugs Standard Control Organization (CDSCO) has given its nod to AstraZeneca to...
Glenmark Pharmaceuticals launches 3-in-1 inhaler therapy AIRZ-FF for COPD in India Ruchika Sharma11 May 2020 1:07 PM ISTMumbai: Glenmark Pharmaceuticals Ltd. announced the launch of a Single Inhaler Triple Therapy AIRZ-FF - a combination of two bronchodilators,...
